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 NOVEL MOLECULES FROM ENVIRONMENTAL DNA-DERIVED  
TYPE II POLYKETIDE BIOSYNTHETIC GENE CLUSTERS 
Ryan W. King, Ph.D. 
The Rockefeller University 2013 
Natural products have been a significant source of new drugs over the 
past 25 years. In fact, the origins of nearly 70% of antibacterial, antifungal, 
antiparasitic and antiviral small molecule drugs are in natural products 
(Newman and Cragg 2007). A significant proportion of natural product drugs 
and leads have been isolated from microbes (Newman and Cragg 2007). 
However, the discovery of novel natural products from microbes faces the 
growing hurdle of rediscovering known metabolites. Streptomyces is a 
microbe that has been a particularly rich source of natural products; 
however, it has been predicted that the last easily accessible novel 
Streptomyces metabolite will be found within the next few years (Watve, 
Tickoo et al. 2001). Finding a new source rich in natural products would be 
very beneficial to the development of new drugs.  
One potential new source of natural products is the plethora of 
uncultured bacteria found in environmental soil samples. It is estimated that 
greater than 99% of bacteria from soil samples are recalcitrant to culturing in 
a laboratory setting. A culture-independent approach of extracting 
 environmental DNA (eDNA) from soil and cloning it into a library was 
leveraged to take advantage of the genetic diversity of uncultured microbes.  
Uncultured microbes have been found to be rich in type II polyketide 
synthase (PKS) gene clusters (Kieser, Bibb et al. 2000). PKS gene clusters produce a 
structurally diverse collection of aromatic natural products. The nascent polyketide in 
these pathways is produced by a conserved minimal PKS, composed of an α-
ketosynthase, β-ketosynthase and acyl carrier protein. In order to access the structural 
diversity encoded by type II PKS gene clusters from uncultured bacteria, environmental 
DNA (eDNA) libraries were constructed from desert soil. These libraries were found to 
be rich in PKS genes and cosmids containing minimal PKS genes were recovered from 
the eDNA library using β-ketosynthase sequences as probes.  The recovered clones 
containing minimal PKS genes from the eDNA library were screened for the ability to 
confer the production of clone-specific molecules to cultured Streptomyces albus.  
One of the recombinant Streptomyces clones was found to produce erdacin, a 26-
carbon polyketide with both a novel carbon backbone and a novel pentacyclic ring 
arrangement. The novel structure and pentacyclic ring arrangement of erdacin 
raised questions as to the biosynthetic origins of this metabolite encoded by 
the eDNA-derived V167 clone. A biosynthetic analysis of wild type and 
transposon mutant V167 cultures indicated that erdacin arises from the 
heterodimerization of two 13-carbon monomer subunits that are both derived 
from octaketide precursors. These two 13-carbon subunits arise from two 
different second cyclizations, but both have the same three carbons excised 
from their 16-carbon octaketide precursors.  
 In addition to erdacin, a number of other clone specific novel and 
known metabolites were characterized from cultures of S. albus conjugated 
with the wild-type V167 clone. These metabolites included utahmycin A, 
utahmycin B and 8-O-methylutahmycin A. The structure of Utahmycin A is 
novel and utahmycin B has not been previously observed in a biological 
system. The identification of the novel structure, erdacin, provides tangible evidence 
that eDNA-derived type II PKS gene clusters may encode the biosynthesis of molecules 
that are distinct from known metabolites identified by traditional culture-based strategies. 
The isolation of additional distinct novel metabolites from the same eDNA 
clone suggests these gene clusters are a rich source of novel natural products. 
In future studies, the heterologous expression of eDNA-derived type II PKS gene 
clusters is likely to be a rewarding avenue to access the structural diversity of 
natural products encoded by uncultured soil bacteria.  
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CHAPTER 1 
Introduction and Background 
Natural Products 
Natural products have been a significant source of new drugs over the 
past three decades. In fact, the origins of nearly 70% of antibacterial, 
antifungal, antiparasitic and antiviral small molecule drugs are in natural 
products (Newman and Cragg 2007). In addition to antimicrobial properties, 
natural products have a wide range of therapeutic applications from 
anticancer to cholesterol-lowering agents. Natural products have been 
isolated from a wide range of sources including microbial, marine, plant and 
even animal sources. A significant proportion of natural product drugs and 
leads have been isolated from microbes (Newman and Cragg 2007). It has 
been estimated that almost two thirds of clinically useful antibiotics are 
derived from the primarily soil dwelling Streptomyces (Kieser 2000).  
The majority of known bacterial natural products are not necessary for 
growth of the bacteria producing them. As a result, these natural products 
are referred to as secondary metabolites. Bacteria will expend the energy to 
produce secondary metabolites to gain a competitive advantage in their 
environment and utilize these metabolites for a number of applications, 
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including defense, cell-cell signaling and siderophore iron scavenging. The 
frequently complex structures of bacterial secondary metabolites are 
produced by groups of biosynthetic enzymes. The genes encoding for these 
biosynthetic enzymes are typically grouped in clusters in the genome of the 
microbe. This gene clustering is believed to have helped facilitate the 
evolution of natural product biosynthetic gene clusters (Maplestone, Stone et 
al. 1992). 
Traditionally to isolate natural products from bacteria, the bacterium 
must first be cultured from a sample. Bacterial cultures are then extracted 
with organic solvents and the metabolites produced can be fractionated and 
assayed for desired activities. However, the number of new natural products 
discovered by this culture-dependant approach is declining (Fox 2006). While 
there are many reasons for this downward trend, one major hurdle has been 
the rediscovery of already known metabolites. In fact, while Streptomyces has 
been a particularly rich source of natural products, it has been predicted that 
the last easily accessible novel Streptomyces metabolite will be found within 
the next few years (Watve, Tickoo et al. 2001). Finding a new source rich in 
natural products would be beneficial to the development of new drugs. 
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Uncultured Microbes and Metagenomics 
One potential new source of natural products is the large number of 
uncultured microbes found in the environment. It has been predicted that 
less than 1% of the bacteria in a given soil sample can be easily cultured 
(Torsvik, Salte et al. 1990; Torsvik, Goksoyr et al. 1990; Hugenholtz, Goebel 
et al. 1998; Torsvik, Daae et al. 1998; Torsvik and Ovreas 2002; Rappe and 
Giovannoni 2003). The large portion of uncultured bacteria in a given soil 
sample are likely to encode for the production of a diverse collection of 
natural products. Difficulties in growing these microbes from soil samples 
hamper traditional culture-dependant approaches from accessing these 
metabolites. In fact, traditional culture dependant approaches have most 
likely missed the majority of natural products in nature (Hugenholtz, Goebel 
et al. 1998; Rappe and Giovannoni 2003). Uncultured bacteria represent a 
large potential untapped source of novel natural products.  
Fortunately, culture-independent metagenomic methods have been 
developed to study the genetic diversity of all the microbes in an 
environmental sample. Metagenomic methods avoid the limitations of 
traditional culture-dependant methods by directly extracting DNA 
representing the entire microbial genetic diversity from the environment. 
Environmental DNA (eDNA) extracted from nature contains an incredible 
amount of genetic material, including secondary metabolite biosynthetic gene 
clusters. This eDNA must then be cloned into a culturable host to enable 
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future analysis. To accomplish this eDNA can be ligated into a cosmid vector, 
packaged into lambda phage and transfected into  E. coli (Brady 2007). This 
cosmid cloning method captures 30-50 kb pieces of eDNA in a single cosmid. 
Since the genes responsible for the biosynthesis of natural products are 
typically clustered together, it is possible to capture an entire biosynthetic 
gene cluster on a single cosmid (Handelsman, Rondon et al. 1998). Large 
libraries of eDNA clones, some containing natural product biosynthetic gene 
clusters, enable the exploration of eDNA-derived genes through subsequent 
screening or sequencing studies.  
Functional metagenomic screening 
One approach to access the structural diversity encoded in eDNA 
libraries is through a functional metagenomic screen (Figure 1). Functional 
metagenomic screening relies on the expression of eDNA clones in a 
heterologous host to identify natural products. In functional metagenomic 
screening, individual clones with phenotypes indicative of small molecule 
production are identified in eDNA libraries by high throughput assays. These 
phenotypes that indicate small molecule production include pigmentation, 
altered colony morphology and/or antibiosis. The pigmentation of clones has 
been used to identify a number of metabolites from soil eDNA including the 
pigments indigo (1), violacein (2) and the turbomycins (3) (Figure 2) 
(MacNeil, Tiong et al. 2001; Brady, Chao et al. 2001; Gillespie, Brady et al. 
2002; Lim, Chung et al. 2005). Furthermore, eDNA libraries hosted in E. coli 
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can be screened for antibiosis in top agar overlay assays to detect zones of 
inhibition against test bacteria such as B subtilis. Clone specific metabolites 
from eDNA clone hits in these overlay assays have been characterized 
leading to the discovery of a novel isonitrile functionalized indole (4) and a 
collection of long-chain N-acylated amines (5) (Figure 2) (Brady and Clardy 
2000; Brady and Clardy 2005).  
 
 
 
Figure 1: Functional and Homology-based metagenomic screening strategies.  
Functional screening relies on heterologous expression while the entire eDNA library is 
assayed in simple high throughput assay. Homology-based screening identifies individual 
clones of interest by PCR that can be subsequently recovered and heterologously expressed.  
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Figure 2: Compounds identified by functional metagenomic screening.  
 
While the terragine (6) compounds have been isolated from the 
heterologous expression of soil eDNA in S. lividans, E. coli has been the host 
utilized in many functional metagenomic studies (Wang, Graziani et al. 2000; 
Banik and Brady 2010). However, it is predicted that E. coli is unable to 
successfully heterologously express much of the genetic information encoded 
by eDNA (Gabor, Alkema et al. 2004). In order to access more of the genetic 
diversity of eDNA, libraries have been constructed in broad-host-range 
vectors that could be moved into multiple phylogenetically distinct bacteria 
for functional screening (Courtois, Cappellano et al. 2003; Martinez, Kolvek 
et al. 2004; Aakvik, Degnes et al. 2009; Craig, Chang et al. 2009). One study 
utilized a broad-host-range vector to construct and screen eDNA libraries in 
six diverse hosts: Agrobacterium tumefaciens, Burkholderia graminis, 
Caulobacter vibrioides, Escherichia coli, Pseudomonas putida and Ralstonia 
metallidurans. This study demonstrated that eDNA clones will present 
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distinctive phenotypes in different hosts and that the same phenotype is 
rarely conferred to two different hosts (Craig, Chang et al. 2009; Craig, 
Chang et al. 2010). 
In addition to small molecules, functional metagenomic screening has 
been used to find proteins of interest, including phage lysins. In fact, a 
functional metagenomic screen has been developed and used to express 29 
phage lysins from environmental samples of animal feces and earthworm 
guts (Schmitz, Daniel et al. 2008; Schmitz, Schuch et al. 2010).   Functional 
metagenomic screening is a powerful technique to gain access to the genetic 
diversity encoded by uncultured bacteria. 
Homology-based metagenomic screening 
Homology-based metagenomic screens take advantage of the sequence 
homology between previously sequenced biosynthetic genes and the 
unidentified biosynthetic genes of uncultured bacteria. In homology-based 
screening, degenerate polymerase chain reaction (PCR) primers are designed 
from previously sequenced conserved regions of a biosynthetic gene of 
interest. PCR screening with these degenerate primers enables the 
identification and recovery of individual clones, which contain a homologous 
gene, from an eDNA library (Figure 1). These degenerate primers can be used 
to find new derivatives of known metabolites by targeting relatively rare or 
pathway-specific biosynthetic genes. Alternatively, these primers can be 
designed to identify novel structures by targeting conserved general 
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biosynthetic genes found in a class of compounds. Once a clone with a gene of 
interested is recovered from an eDNA library, it can be moved into an 
appropriate heterolgous host for expression.  
New derivatives of known metabolites 
A number of studies have utilized homology-based metagenomic 
approaches to identify genes that can be used to develop new derivatives of 
known compounds (Donia, Hathaway et al. 2006; Schmidt and Donia 2009; 
Ziemert, Ishida et al. 2010). Banik et al. have used a PCR screen targeting 
OxyC, a glycopeptide oxidative coupling enzyme, to identify and recover a 
number of glycopeptide biosynthetic gene clusters from a soil eDNA library 
(Banik and Brady 2008; Banik, Craig et al. 2010). One of these recovered 
gene clusters was found to contain three sulfotransferases that were 
subsequently used to produce novel mono-, di- and trisulfated glycopeptide 
congeners from the teicoplanin aglycone (Figure 3) (Banik and Brady 2008). 
A follow up study found additional tailoring enzymes that were used to 
generate a collection of 15 new sulfated, glycosylated, halogenated and 
methylated glycopeptide congeners (Banik, Craig et al. 2010).  
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Figure 3: Sulfated glycopeptides.  
Three eDNA-derived sulfotransferases were used to produce mono-, di- and trisulfated 
glycopeptide congeners from teicoplanin aglycone. 
Novel Structures 
Homology-based metagenomic screens can be designed to find novel 
structures by targeting conserved general biosynthetic genes found in a class 
of compounds. Type-II polyketide synthase (PKS) gene clusters contain a 
highly conserved minimal PKS composed of two ketosynthase genes (KSα 
and KSβ) and an acyl carrier protein (discussed in more detail below). Type II 
PKS genes first became targets of homology-based metagenomic screens 
when two KSβ genes were cloned from eDNA in 1997 (Seow, Meurer et al. 
1997). High throughput sequencing studies have indicated that eDNA 
contains an abundance of novel PKS gene clusters (Wawrik, Kerkhof et al. 
2005; Pang, Tan et al. 2008; Warwrik, Kutliev et al. 2007)). However, it has 
been a challenge to identify eDNA clones with intact gene clusters that can 
successfully heterologously express small molecules (Piel, Hui et al. 2004; 
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Schirmer, Gadkari et al. 2005; Courtois, Cappellano et al.2003). In fact, prior 
to the work presented in this thesis, no new metabolites had been isolated 
from eDNA-derived type II PKS gene clusters (Figure 4).  
 
Figure 4: Homology-based metagenomics screen for Type II PKS gene clusters  
Scheme for the recovery and heterologous expression of Type II PKS clones from an eDNA 
library. 
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After the discovery of erdacin, a novel polyketide with both a novel 
carbon skeleton and ring system, a number of other aromatic polyketides 
have been isolated from soil libraries (Figure 5) (King, Bauer et al. 2009). 
These metabolites include compound 8, a second eDNA-derived type II 
polyketide found to have both a novel carbon skeleton and ring system (Feng, 
Kallifidas et al. 2011). The antibiotic fasamycins (9) were isolated from soil 
and found to inhibit FabF of type II fatty acid biosynthesis (Feng, Kallifidas 
et al. 2011; Feng, Chakraborty et al. 2012). A collection of fluostatins (10) and 
the methicillin-resistant Staphylococcus aureus (MRSA)-active antibiotic 
tetarimycin A (11) have also been isolated from soil libraries (Feng, Kim et al. 
2010; Kallifidas, Kang et al. 2012). In addition to isolating polyketides, a 
homology-based metagenomic screen targeting oxy-tryptophan dimerization 
has found an eDNA-derived gene cluster that encodes the biosynthesis of the 
antitumor substance BE-54017 (12) (Chang and Brady 2011). Homology-
based metagenomic screening is proving to be a rewarding avenue to access 
the structural diversity encoded by uncultured bacteria.  
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Figure 5: Metabolites isolated in homology-based metagenomic screening.  
Four aromatic polyketides and the antitumor substance BE-54017 were all isolated from soil 
eDNA libraries. 
Polyketides  
Polyketides are an incredibly valuable class of natural products 
produced by plants, bacteria and fungi. The over 10,000 compounds in this 
class have therapeutic applications as antibiotic, immunosuppressant, 
anticancer, antifugal, antiparasitic and cholesterol-lowering drugs (Figure 
6a) (Walla, Bearden et al. 2002; McMurry and Begley 2005; Lombó, 
Abdelfattah et al. 2009). Polyketides are subdivided into three classes based 
on their enzymatic architecture: type I, type II and type III (Staunton and 
Weissman 2001; Fujii 2008). Type I polyketide synthetases are made up of 
large multifunctional proteins that each contain multiple functional domains. 
These catalytic domains, including a ketosynthase (KS), acyltransferase, acyl 
carrier protein (ACP) and other modification domains, are organized into 
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modules. Type I PKSs are further divided into multi-modular (mPKS) and 
single modular iterative (iPKS) categories. Type II PKSs are composed of a 
number of separate individual enzymes that form a multi-enzyme complex. 
Type III PKSs have a simple architecture compared to other polyketides. 
They are composed of a homodimer of condensation subunits and can utilize 
acyl-CoA without the use of an ACP.  
Most bacterial aromatic polyketides are encoded by type II PKS gene 
clusters (Fujii 2008). Type II polyketide gene clusters contain a conserved 
genetic arrangement known as the minimal PKS, which is composed of an α-
ketosynthase (KSα), a β-ketosynthase (KSβ; aka. chain length factor) and an 
ACP. The minimal PKS is responsible for synthesizing the nascent polyketide 
by iteratively condensing malonyl-CoA units (Figure 6b). The minimal PKS is 
also responsible for catalyzing the first cyclization of the nascent polyketide it 
produces. Nature has derived an astonishing array of post-PKS and tailoring 
enzymes that cyclize, aromatize, reduce, rearrange and functionalize nascent 
polyketides into an incredibly diverse collection of natural products (Figure 
6a) (McDaniel, Khosla et al. 1995; Matharu, Cox et al. 1998 Shen 2000; 
Hertweck, Luzhetskyy et al. 2007).  
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Figure 6: Type II Polyketides and the minimal PKS. 
A) Examples of type II polyketides include the antibiotics actinorhodin (13) and tetracycline 
(14), the antitumor oviedomycin (15), the antifungal jadomycin B (16) and the anticancer 
drug doxorubicin (17). B) The highly conserved minimal PKS (KSα, KSβ and ACP) of type II 
PKS gene clusters iteratively condenses malonyl-CoA units into a nascent polyketide. 
 
The iterative use of the minimal PKS typically makes type II PKS gene 
clusters smaller than other pathways encoding comparably complex 
molecules. This makes type II PKS pathways an attractive target for 
homology-based metagenomic screening, because entire type II PKS gene 
clusters are more easily captured on a single 30 to 50 kb eDNA cosmid insert. 
Furthermore, these biosynthetic systems only require universal substrates, 
which will be present in a heterologous host, to produce the nascent 
polyketide. The use of universal precursors by the biosynthetic machinery 
will help enable expression in a heterologous host. In fact, there is extensive 
precedent for the expression of type II PKS gene clusters in Streptomyces. 
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Furthermore, even a truncated gene cluster with an intact minimal PKS can 
be functional. As a result, it maybe possible to determine the novelty of a 
metabolite encoded by an incomplete truncated type II PKS gene cluster 
captured on a cosmid.  
Type II PKS genes are an ideal target for homology-based 
metagenomic screening of eDNA libraries to find novel natural products 
because type II PKS pathways produce structurally diverse metabolites, are 
small enough to capture on a single cosmid, require universal substrates and 
have precedent of being heterologously expressed in Streptomyces. The 
exploration of type II PKS gene clusters from eDNA libraries is likely a 
rewarding avenue to gain access to an incredible amount of the structural 
diversity encoded by uncultured bacteria.  
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CHAPTER 2 
Materials and Methods  
General Experimental Procedures 
Streptomyces albus J1074 was used for heterologous expression 
studies. 1H and 2D NMR data were obtained on a Bruker Avance-600 
spectrometer. 13C NMR spectra were obtained on a Bruker Avance-400, 
Bruker Avance-800 spectrometer or Bruker Avance-900 spectrometer. 
Melting points were obtained on a Stanford Research Systems MPA100 
OptiMelt melting point apparatus. A Varian Cary 100-Bio UV-vis 
spectrophotometer was used to collect UV data. And a Bruker Tensor-27 
spectrometer was used to obtain IR data. 
eDNA Library Construction and Formatting 
Soil collected in Utah (UT) or the Anza-Borrego (AB) desert in 
California was used to construct a cosmid eDNA library following methods 
previously described (Brady 2007; Banik and Brady 2008). Soil was incubated 
for two hours at 70°C in lysis buffer (2% SDS (w/v), 100 mM Tris-HCl, 100 
mM EDTA, 1.5 M NaCl and 1% CTAB (w/v)). Large particulates were 
removed from the sample by centrifugation at 4,000 × g for 30 min. DNA was 
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then precipitated by the addition of 0.6 volumes of isopropyl alcohol and 
pelleted by centrifugation at 4,000 × g for 30 min. The resulting pellet was 
washed with 70% ethanol and resuspended in TE. This DNA was gel purified 
on a 1% agarose gel for 16h at 20V. The resulting high molecular weight 
eDNA was blunt-ended (End-It, Epicentre), ligated into pWEB or pWEB-TN 
(Epicentre) and packaged into lambda phage. E. coli EC100 was transfected 
and 4,000 - 16,000 colonies per plate were plated on a LB plates with the 
appropriate antibiotic selection. Matching glycerol stock (15% glycerol) and 
DNA miniprep pairs were made from the cells scraped from each library 
plate. The miniprep DNA from each of these 4,000-16,000 member library 
pools were arrayed in 8 X 8 grids. To make screening of the library easier, 
DNA from the rows and columns of this 8 X 8 grid were pooled. These pooled 
rows and columns were further combined to yield master aliquots, each 
representing a single 8X8 grid of minipreps. 
PCR Screening of eDNA Libraries for KSβ  Genes  
The constructed eDNA libraries were for screened for KSβ genes by 
PCR. Full-length KSβ genes were amplified from eDNA library pools using 
the following pair of degenerate PCR primers (Seow 1997): dp:KSα, 5’ TTC 
GGS GGX TTC CAG WSX GCS ATG and dp:ACP, 5’ TCS AKS AGS GCS 
AXS GAS TCG TAX CC (X=deoxyinosine). The 25 µl PCR reactions each 
contained 50 ng of eDNA template, 2.5 µM of each primer, 2 mM dNTPs, 1X 
ThermoPol Reaction Buffer (New England Biolabs), 0.5 U Taq DNA 
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polymerase (New England Biolabs) and 5% DMSO. A touchdown PCR 
protocol was used in the initial screening of the libraries: denaturation (95°C; 
45s), annealing (touchdown of 65°C to 58°C over 8 cycles D-1°C, followed by 
58°C for 35 cycles; 1min) and extension (72°C; 2 min). Amplicons of the 
correct predicted size (~1.5 kb) were identified by gel electrophoresis, gel 
purified and sequenced by Sanger sequencing (Biotic Solutions).   
Clone Recovery from eDNA libraries 
As described above, sub-library pools with PKS containing clones were 
initially identified by PCR screening of eDNA for KSβ sequences. Individual 
clones of interest were then recovered from the corresponding glycerol stock 
in the eDNA library using successive rounds of library dilution and PCR 
screening. Briefly, a 10-4 dilution of the corresponding library glycerol stock 
resuspended with LB to an OD600=0.2. was prepared. This 10-4 dilution (20 µl) 
was then added to each of the individual wells of two to four 96-well 
microtiter plates prefilled with LB (with the appropriate antibiotic selection). 
These plates were incubated at 30°C overnight and 1 µl of this cell culture 
from each well was used as template in whole cell PCR. Individual colonies 
from PCR positive wells were then screened by colony PCR to identify 
individual clones containing KSβ sequences. In some cases a second round of 
dilution PCR screening of a single PCR positive well was required before 
individual colony PCR could be utilized.  
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eDNA Clone Sequencing 
PKS containing cosmids recovered from the eDNA libraries were 
initially sequenced by 454 pyrosequencing (Roche) by Memorial Sloan 
Kettering Cancer Center Genomics Core Laboratory. Reads were processed 
with Newbler (Roche) and Velvet (Zerbino and Birney 2008). Sequence gaps 
between assembled contigs generated during 454 sequencing were filled by 
primer walking (Biotic Solutions). The size and deduced role of the open 
reading frames of sequenced cosmids were predicted using Glimmer 
(Salzberg, Delcher et al. 1998), SoftBerry (Tyson et al. 2004) and BLAST 
(Gish and States 1993). MacVector was used for sequence manipulation.  
Clone Retrofitting and Integration into S. albus 
Clones recovered from the eDNA libraries were retrofitted so that they 
could be integrated into Streptomyces for heterologous expression studies. 
The cassette used for retrofitting was constructed from the integrating vector 
pOJ436. pOJ436 was digested with DraI and ligated with SmaI cut pBC. The 
resulting vector was digested with XbaI and SpeI to create the desired 
retrofitting cassette. Recovered eDNA clones were digested with rare 
restriction enzymes (AvrII, NheI or PstI) to ensure that only the pWEB or 
pWEB-TNC vector was cut and not the eDNA insert. The XbaI/SpeI cut 
pOJ436 cassette was ligated directly into eDNA clones cut with AvrII or 
NheI. The V167 clone was one such clone digested with AvrII for ligation into 
the retrofitting cassette. Clones cut with PstI were blunt ended (End-It, 
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Epicentre) and ligated into a blunt ended retrofitting cassette. The retrofitted 
clones were then transformed into E. coli S17-1 and conjugated into S. albus 
using standard Streptomyces conjugation protocols (Kieser, Bibb et al 2000).  
Expression, Isolation and Characterization of Erdacin and 
Juglomycin F from the V167 Clone 
A spore stock of S. albus transformed with the retrofitted V167 clone 
(25 mL) was inoculated into 75 mL of modified supplemented minimal 
medium (SMM). Cultures larger than 75 mL yielded lower titers of erdacin. 
Modified SMM contained: 819 mL PEG 6000 (6.1%), 25 mL MgSO4⋅7H2O (24 
g/L), 100 mL TES Buffer (0.25 M, pH 7.2), 2 mL Glucose (50% w/v), 1 mL 
SMM Trace Element Solution, 1 mL casamino acids (20% w/v) and 25 mL 
Glycine (20%). Uniformly labeled 13C-erdacin was isolated from V167 cultures 
grown in modified SMM containing uniformly labeled 13C-glucose and 
uniformly labeled 13C-glycine. Erdacin labeled with [1,2-13C]acetate was 
obtained by feeding V167 cultures grown in modified SMM three equal 
portions of a sodium acetate solution at 24, 48 and 72 hours to attain a final 
acetate concentration of 1.1 mM [1,2-13C]acetate and 2.2 mM naturally 
abundant acetate. 
V167 cultures were incubated for 4 days at 30°C and 250 rpm. The pH 
of these cultures was adjusted to 3 with HCl and they were extracted two 
times with an equal volume of ethyl acetate. The dried extracts were 
dissolved in methanol (2-4 mL/L of culture) and passed through a SPE 
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Previal C-18 plug.  The sample was then dried, redissolved in 1-2 mL of 
methanol, and partitioned by reversed phase HPLC (XBridge C18, 10 × 150 
mm, 5 mm, gradient (Table 1) of acetonitrileand water with 0.1% formic acid, 
7 mL/min). Fractions containing erdacin (14.9 min) and juglomycin F (8.6 
min) were dried down overnight in a speed vac and analyzed by MS and 
NMR. Plate-like crystals of erdacin were obtained by slow evaporation from a 
mixture of acetonitrile and water. X-ray crystallography was done by E. 
Lobkovsky at Cornell University and deposited in the Cambridge 
Crystallographic Data Centre (CDCC). 
 
Table 1: HPLC gradient for isolating erdacin and juglomycin F 
Time (min) 
% Water with 0.1% 
formic acid % Acetonitrile 
Initial 80 20 
2 80 20 
26 50 50 
27 0 100 
32 0 100 
35 80 20 
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CUPRAC Antioxidant assay of Erdacin 
The antioxidant activity of erdacin was determined using the CUPRAC 
antioxidant assay (Apak, Kubilay, et al 2004). Cupric chloride dihydrate (10 
mM in water, 25 µL), 25 µL 1M ammonium acetate and 25 µL 7.5 mM 
neocuproine (in ethanol) were added to the wells of a 96-well plate.  Control 
wells of the reaction solution containing 25 µL of water, 25 µL ammonium 
acetate (1 M) and 25 µL of ethanol were prepared. Two fold serial dilutions 
(final concentration from 400 mM to 95 fM) of erdacin and ascorbic acid were 
prepared. Each of the serial dilutions was added (25 µL) to a well containing 
the 75 µL reaction or control mixtures.  
After incubating at room temperature for one hour, the absorbance of 
each well at 450 nm was measured on a 96-well plate reader. Recorded 
absorbances of the ascorbic acid dilution series were blanked against a 
reagent blank. The erdacin dilution series was blanked against a reagent 
blank and further adjusted by subtracting the absorbance of a well 
containing 25 µL of the appropriate erdacin dilution, 25 µL of water, 25 µL of 
1M ammonium acetate and 25 µL of ethanol. Absorbance vs. concentration 
was plotted and the molar absorptivity (ε) under the reaction conditions was 
calculated from the slope of the linear range for both erdacin (2.58 × 104 L 
mol-1cm-1) and ascorbic acid (1.29 × 104 L mol-1cm-1).  The observed value for 
ascorbic acid was comparable to the previously reported value of 1.59 × 104 L 
23 
 
mol-1cm-1. The molar absorptivity (ε) calculation where A is absorbance, L is 
pathlength, ε is molar absorptivity, c is concentration and m is the slope of 
the line plotted in the experiment: 
A = L × ε × c 
m = L × ε 
εerd = (m erd)/(L) = (5157.1 L mol-1)/(0.2cm) = 2.58 × 104 L mol-1cm-1 
εascorbic acid = (mascorbic acid)/(L) = (2574.5 L mol-1)/(0.2cm) = 1.29 × 104 L mol-1cm-1 
Expression, Isolation and Characterization of Utahmycin 
A, Utahmycin B and 8-O-methylutahmycin A 
A number of metabolites were observed under alternative culture 
conditions of the V167 clone. These metabolites were isolated and 
characterized. A spore stock of S. albus transformed with the retrofitted V167 
clone (75 mL) was inoculated into two 1 L flasks of modified R2YE medium. 
Modified R2YE medium was prepared by adding 10 mL KH2PO4 (0.5%), 80 
mL CaCl22H2O (3.68%), 15 mL L-proline (20%), 25 mL TES buffer (5.73%, 
pH 7.2), 2 mL R2 trace element solution, 5 mL NaOH (1M) and 50 mL yeast 
extract (10%) to a sterile 800 mL solution containing 103 g of sucrose, 250 mg 
K2SO4, 10.12 g MgCl26H2O, 10 g glucose and 100 mg casaminoacids.  
After incubating at 30°C with shaking (250 or 300 rpm) for 7-14 days, 
the pH of these cultures was adjusted to 3 with HCl and extracted with an 
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equal volume of ethyl acetate twice. The dried, crude extracts were then 
fractionated by silica flash chromatography using a chloroform/methanol 
gradient in which 100-150 mL fractions were collected for each of the 
following chloroform/methanol ratios: 100:0, 99:1, 97:3, 95:5, 90:10, 80:20 and 
0:100. The 99:1 fraction was found to contain both utahmycin A and B by 
TLC. This fraction was further partitioned by reversed phase HPLC 
(XBridge C18, 10 × 150 mm, 5 mm, gradient (Table 2) of acetonitrile and 
water with 0.1% formic acid, 7 mL/min). The fractions containing utahmycin 
A (16.5 min, 1 mg/L) and B (12.0 min, 2.5 mg/L) were dried down and 
analyzed by HRMS and NMR. The structure of utahmycin A was confirmed 
by X-ray crystallography	   of	   crystals	   obtained	   by	   slow	   evaporation	   from	  dichloromethane. An alternative HPLC gradient (Table 3) was used to isolate 
8-O-methylutahmycin A, observed in some R2YE cultures of V167. 8-O-
methylutahmycin A (25.0 min, less than 0.5mg/L) was characterized by 
1HNMR and HRMS.  
Table 2: HPLC method for isolating utahmycin A and B  
Time (min) 
% Water with 0.1% 
formic acid % Acetonitrile 
Initial 80 20 
2 80 20 
32 0 100 
37 0 100 
40 80 20 
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Table 3: HPLC method for isolating 8-O-methylutahmycin A 
Time (min) 
% Water with 0.1% 
formic acid % Acetonitrile 
Initial 80 20 
2 80 20 
22 50 50 
27 0 100 
30 80 20 
Expression and Isolation of Prechrysophanol  
Prechrysophanol was observed in cultures of the wild type V167 grown 
in R2YE media for 14 days and in cultures of Erd20 transposon mutants 
grown in SMM.  Pure prechrysophanol was obtained by Dr. John Bauer from 
ethyl acetate extracts of wild type V167 grown in R2YE for 14 days at 30°C 
and 250 rpm. A linear HPLC gradient (Table 4) of acetonitrile and water with 
0.1% formic acid was used to isolate prechrysophanol (14.5 min). Dr. John 
Bauer elucidated the structure of prechrysophanol by NMR and X-ray 
crystallography. NMR and MS was used to confirm the presence of 
prechrysophanol in cultures of Erd20 transposon mutants in this thesis. 
Table 4: HPLC method for isolating prechrysophanol 
Time (min) 
% Water with 0.1% 
formic acid % Acetonitrile 
Initial 80 20 
2 80 20 
26 40 60 
27 0 100 
32 0 100 
35 80 20 
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Transposon Mutagenesis of V167 and Anaylsis of the 
Transposon Mutants 
Transposon mutagenesis of the retrofitted V167 cosmid was carried out 
using the Genome Priming System with GPS®-2.1 (NEB). Two independent 19 
µL GPS reaction mixtures (1X GPS Buffer, 0.01 µg pGPS2.1 Donor DNA, 300 
ng V167 cosmid, and 1U TnsABC* Transposase) were incubated for 10 min at 
37°C. After adding 1 µL of Start Solution, the reactions were incubated at 
37°C for an additional hour, heat inactivated for 10 min at 75°C and 
transformed into EC100 E. coli (Epicentre). Transformants that grew on 
chloramphenicol (12.5 µg/mL) plates were pooled, minipreped and 
transformed into electrocompetent S17-1 E. coli.  
Using sequencing Primer S (ATA ATC CTT AAA AAC TCC ATT TCC 
ACC CCT; NEB) 150 unique transposon mutants were sequenced to 
determine the location of the individual transposon insertions. Unique 
transposon mutants were individually mated into S. albus and visually 
screened for phenotypic changes on mannitol soya plates. Spore stocks of 
individual transposon mutants, which either exhibited a phenotypic change 
or were found in genes of interest, were inoculated into 75 mL cultures of 
modified SMM. After shaking (250 rpm) at 30°C for 4 days, these cultures 
were extracted twice with an equal volume of ethyl acetate. The pH of the 
remaining aqueous layer was adjusted to 3 with HCl and extracted two more 
times with an equal volume of ethyl acetate. The ethyl acetate extracts were 
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dried, dissolved in methanol (200 µL) and analyzed by analytical LC-MS 
(XBridge C18 (4.6 × 150 mm; 5 mm), 1.5 mL/min, acetonitrile and water 
with 0.1% formic acid gradient).  
Table 5: Analytical HPLC method used for transposon mutant analysis  
Time (min) 
% Water with 0.1% 
formic acid % Acetonitrile 
Initial 80 20 
2 80 20 
22 0 100 
27 0 100 
30 80 20 
 
Table 6: HPLC method used to purify SEK34, SEK34b, mutactin and 
dehydromutactin 
 
 
 
 
 
 
Table 7: HPLC method used to purify SEK4b and AUR367  
Time (min) 
% Water with 
0.1% formic acid % Acetonitrile 
Initial 80 20 
20 65 35 
25 50 50 
26 0 100 
30 0 100 
33 80 20 
35 80 20 
Time (min) 
% Water with 
0.1% formic acid % Acetonitrile 
Initial 85 15 
25 80 20 
26 0 100 
30 0 100 
33 85 15 
35 85 15 
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Expression, Isolation and Characterization of SEK4b, 
AUR367, mutactin, dehydromutactin, SEK34 and SEK34b 
from V167 Mutants 
The compounds present in extracts from S. albus transformed with 
transposon mutants in Erd4, 5 and 22 were purified and characterized by MS 
and NMR. Transposon mutants were grown and extracted in the same 
manner described for wild type V167 cultures.  SEK34 (5.9 min) and SEK34b 
(9.8 min) were isolated from crude extracts of the ΔErd22 mutant with an the 
HPLC gradient (Table 6) of acetonitrile and water with 0.1% formic acid. 
Mutactin (6.9 min) and dehydromutactin (10.4 min) were purified from 
extracts of the ΔErd4 GPS mutant using the same HPLC conditions. SEK4b 
(8.1 min) and AUR367 (12.2 min) were isolated from cultures of the ΔErd5 
mutant using an alternative HPLC gradient (Table 7) of acetonitrile and 
water with 0.1% formic acid. MS and 1H NMR data were used to confirm the 
identity of each known compound.  SEK4b (HR-ESI-MS m/z 285.0791, calcd. 
for C16H13O5, 285.0763; SEK34b) was crystallized from acetonitrile:water and 
its structure was confirmed by X-ray crystallography.   
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CHAPTER 3 
Results 
Library Construction and Screening for Type II PKS 
Pathways 
 In order to access the genetic diversity of uncultured microbes, the lab 
constructed a ten million-member cosmid eDNA mega-library from soil 
collected from the desert in Utah (UT). Degenerate primers targeting 
conserved regions of the KSα and ACP of the minimal PKS were used by Dr. 
John Bauer to amplify full-length KSβ sequences from the UT eDNA library. 
Sequencing of these KSβ amplicons revealed that, of the 21 KSβ genes 
amplified from the UT eDNA library, only one showed greater than 80% 
identity to a previously sequenced KSβ gene (Figure 7). A rule of thumb 
based on BLAST searches of KSβ genes indicates that two KSβ genes with 
greater than 80% identity likely encode for the same metabolite. While two 
KSβ genes with less than 80% identity likely encode for different metabolites. 
The low identity these UT eDNA-derived KSβ genes had with previously 
sequenced KSβ genes suggests they are not associated with known PKS gene 
clusters and likely encode for novel metabolites.  
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Figure 7: Phylogenic tree of sequenced KSβ  amplicons from the UT library.  
KSβ amplicons from the UT library sequenced by Dr. John Bauer. Only the UT-N8 KSβ 
amplicon showed greater than 80% identity to a previously sequenced actinorhodin KSβ 
gene. The low identity the other KSβ amplicons had with known genes indicates they are not 
associated with known PKS gene clusters and likely encode for novel metabolites. 
Later, a second multimillion-member cosmid eDNA library was 
constructed by the lab from soil obtained from the Anza-Borrego (AB) desert 
in California. Screening of the AB library pools with degenerate primers 
indicated that the AB library is rich in type II PKS genes. Roughly one in 
every 12,000 clones in the AB library contains a KSβ gene. This high 
frequency of KSβ genes in the library may represent many unique gene 
clusters or a few profuse gene clusters. To distinguish these possibilities, KSβ 
gene amplicons, generated during the PCR screening of the AB library pools, 
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were sequenced to determine if the AB library was rich in unique KSβ genes. 
Of the 61 KSβ genes sequenced, 31 likely represent unique PKS gene clusters 
(Figure 8). Of these 31 unique KSβ genes identified in the AB library, 30 have 
less than 80% identity to previously sequenced KSβ genes and likely encode 
for novel metabolites. One KSβ gene makes up 38% (23/61) of the KSβ genes 
detected in the AB library. The closest homolog to this abundant KSβ gene is 
from the actinorhodin pathway of S. coelicolor. A second unique KSβ gene 
with homology to the actinorhodin gene cluster of S. coelicolor is represented 
8 times. Two unique KSβ genes with closest homologs from S. antibioticus 
were both represented 3 times and the remaining 27 unique KSβ genes were 
each represented once. This sequencing data suggests the AB library is a rich 
source of unique novel type II PKS gene clusters.  
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Figure 8: Phylogenic tree of sequenced KSβ  genes amplified from the AB library.  
Of the 31 unique KSβ genes identified in the AB library, 30 had less than 80% identity to a 
previously sequenced KSβ gene and likely encode for novel metabolites. 
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Recovery and Heterologous expression of eDNA-derived 
Type II PKS pathways   
PKS containing clones were recovered from the eDNA library and were 
heterologously expressed in order to access the structural diversity encoded 
by these gene clusters from uncultured bacteria. Clones containing PKS gene 
clusters were recovered from the libraries using KSβ genes as probes in 
successive rounds of library dilution and PCR screening. Dr. John Bauer 
recovered twelve unique eDNA clones containing type II PKS gene clusters 
from the UT eDNA library for heterologous expression studies. And with 
Paula Calle’s assistance, nearly two dozen more clones containing PKS genes 
were recovered from the other AB library during the course of this work.   
Knowing that any PKS gene clusters from the library that could be 
heterologously expressed in E. coli would likely have been identified in 
earlier phenotypic screens of the library, an alternative heterologous host, 
Streptomyces, was selected for expression studies. The predominantly soil 
dwelling gram-positive Streptomyces is synonymous with secondary 
metabolite production and produces two-thirds of clinically useful antibiotics 
derived from natural sources (Kieser, Bibb et al. 2000). Streptomyces have 
extensive precedent as a successful heterologous host. Furthermore, nearly 
all of the identified KSβ genes in this work have closest homology with KSβ 
genes from Streptomyces. In fact, only one of 31 KSβ genes identified in the 
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AB library had a closest homolog from outside Streptomyces. The closest 
homolog of this gene was with an Actinomadura verrucosospora KSβ gene.  
Recovered clones from the libraries containing type II PKS gene clusters were 
retrofitted so that they could be conjugated into Streptomyces for 
heterologous expression studies. Rare restriction enzymes (AvrII, NheI, PstI 
or PsiI) were used to remove PKS gene containing eDNA inserts from the 
library construction vector, without cutting the eDNA insert. The resulting 
intact linear eDNA was then ligated into the integrating Streptomyces shuttle 
vector pOJ436. These retrofitted clones were transformed into E. coli S17-1 
donor strain and conjugated into Streptomyces using standard Streptomyces 
conjugation protocols. Dr. John Bauer successfully retrofitted and conjugated 
eight clones from the UT library into S. albus. Retrofitting and conjugation of 
the AB library clones was done by Dr. Sean Brady and myself, respectively, 
with the assistance of Paula Calle.  
While other Streptomyces species were explored, Streptomyces albus 
proved to be an exceptional, laboratory friendly heterologous host because of 
its fast growth rate, ample sporulation and ease of mating. These factors 
helped facilitate both the conjugation of eDNA-derived Type-II PKS gene 
clusters into S. albus and the characterization of the molecules these 
pathways encode for. Eight of the clones recovered from the UT library were 
retrofitted with the genetic elements necessary for integration into 
Streptomyces and were successfully transformed into S. albus.  
35 
 
Recombinant S. albus clones from the UT and AB libraries were then 
screened for the production of clone specific metabolites. Antibacterial 
overlays, color production, TLC and HPLC-MS analysis were used to 
identified clone specific metabolites from cultures and crude extracts of 
recombinant clones (Figure 9). Five of the recombinant strains from the UT 
library were first observed by Dr. John Bauer to produce clone specific 
metabolites. An equivilant number of recombinant strains from the AB 
library were also observed to produce clone specific metabolites by visual 
inspection, TLC, or HPLC-MS of crude extracts. Two of these clones from the 
UT library (V167 and X26) and two clones from the AB library (848 and 1105) 
were examined in this work. However, the V167 clone was selected for a proof 
of principle study because, it produced large quantities (15-20 mg L-1) of a 
purple clone specific metabolite (King, Bauer et al. 2009; Bauer, King et al. 
2010).  
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Figure 9: S. albus transformed with eDNA-derived PKS clones were screened for 
the production of clone specific metabolites. 
Representative images of the screening process. A) Recombinant S. albus on MS agar plates 
to screen for colored metabolite production. The V167 and X26 clone are pictured. B) Crude 
neutral and acid ethyl acetate extracts of cultures spotted on a lawn of B. anthrasis in an 
antibacterial disk diffusion assay for four clones. C) Analytical LCMS trace of crude V167 
culture extracts. V167 was selected for further studies because of the large quantities of 
clone specific metabolite it produced.  
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Isolation and Structural Characterization of eDNA 
Encoded Natural Products 
To learn more about the molecules encoded by eDNA-derived Type-II 
PKS gene clusters, the major clone specific metabolite of the recombinant S. 
albus V167 clone was isolated and structurally characterized. Attempts were 
made to isolate and structurally characterize metabolites from other clones, 
including the X26 clone recovered from the UT library. However, the array of 
clone specific metabolites from the X26 clone appeared to be unstable and 
attempts to isolate them were unsuccessful. Efforts were focused on the 
isolation and structural elucidation of one clone specific metabolite produced 
in large quantities by the V167 clone.  
Cultures of S. albus transformed with the retrofitted V167 clone were 
grown in modified supplemented minimal medium (SMM). After incubating 
at 30°C for 4 days, the cultures were acidified to pH 3 and extracted with 
ethyl acetate. This crude extract was passed through a SPE Previal C-18 
plug and further partitioned by reversed phase HPLC to isolate the major 
metabolite, erdacin (HRMS (ESI) m/z 475.1037 [M+H]+, calcd. for C26H19O9, 
475.1029). An extensive 1- and 2-D NMR analysis of naturally abundant and 
uniformly 13C-labeled erdacin utilizing 1HNMR, 13CNMR, COSY, HMBC, 
HMQC and INADEQUATE was used to assemble a potential structure of the 
metabolite (Figure 10a).  
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Proton NMR revealed six aromatic protons, two methyls and one 
deshielded methanetriyl (4.29 ppm). The six aromatic protons included a 
triplet, three doublets and two protons in a multiplet. HMBC and COSY 
showed the triplet (7.28 ppm) and two of the doublets (6.92 and 7.16 ppm) 
formed a spin system. The remaining aromatic doublet (6.73 ppm) must 
couple with at least one of the protons in the multiplet (7.40 ppm). Given the 
complexity of the multiplet, a second d-t-d spin system can be assumed. This 
second spin system was confirmed in 1HNMR and HMBC of chemically O-
methylated erdacin where this multiplet was resolved into a distinct triplet 
and doublet (data not shown).  
Carbon NMR was done on uniformly 13C-labeled erdacin to increase 
carbon signal intensity. This carbon NMR data confirmed 26 carbon signals 
including the two methyl carbons, four carbonyls, two deshielded sp3 
hybridized carbons and 18 olefins. HMBC and HMQC further showed the two 
methyl groups were methyl ketones, where one was attached to an olefin (C-
4) and the other to C-13 (64.6 ppm). Based on 13C chemical shift, the two 
remaining carbonyls include an unsaturated ketone (C-1, 188.8 ppm) and a 
carboxylic acid (C-24, 176.6 ppm). Deshielding on three of the olefins 
suggested they were attached directly to heteroatoms. And HMQC revealed 
six olefins that were directly attached to the six aromatic protons.  
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The H-7, 8 to 9 spin system can be connected into an aromatic ring 
fragment with the olefins C-6, 10 and 11 based on HMBC correlations 
between these hydrogens and carbons. C-10 is one of the olefins attached 
directly to a heteroatom. HMQC determined the 4.29 ppm proton singlet was 
attached to a deshielded sp3 hybridized carbon (C-13, 64.6 ppm). HMBC 
correlations from this H-13 singlet to C-5, 12, 14, 24, 25 and 26 enabled the 
assembly of a fragment containing the two deshielded sp3 hybridized carbons, 
two olefins, the carboxylic acid and one of the methyl ketones. This fragment 
could then be connected to the H-7, 8 to 9 spin fragment to form partial 
structure 18-1 through two correlations between H-13 to C-11 and H-7 to C-5 
(Figure 10a).  
Based on HMBC correlations, the H-17, 18 to 19 spin system could also 
be assembled into an aromatic ring fragment with olefins C-16, 20 and 21. 
Deshielding of C-21 in carbon NMR suggests it is directly attached to a 
heteroatom. The placement of the unsaturated ketone (C-1) adjacent to C-21 
to form fragment 18-2 is consistent with observed chemical shifts and 2D 
INADEQUATE NMR data.  
These two partial structures (18-1 and 18-2) could be connected based 
on two key HMBC 1H-13C correlations to the olefin C-15 from H-17 and H-13. 
However, five carbons (C-2, C-3, C-4, C-22 and C-23) could not be assigned 
with certainty because of weak NMR signals. These remaining carbons 
included three olefins and required two ring closures to meet unsaturation 
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requirements. One of these olefins was attached to a methyl ketone and 
another was directly attached to a heteroatom (Figure 10b). There were a 
limited number of ways to attach these remaining pieces to partial structure 
18-3 while closing two additional rings. Presented structure 18 is the 
possibility most consistent with all of the collected NMR data. However, it is 
difficult to distinguish by NMR this structure from the alternative structure 
where the positions of the C-2 hydroxyl and the C-4 methyl ketone are 
switched (Figure 10b).  
Ultimately, the structure of erdacin was resolved by X-ray 
crystallography of crystals obtained by slow evaporation from acetonitrile and 
water (Figure 10c). The structure of erdacin revealed a potential C-2 hydroxy-
assisted C-22 carbonyl tautomerization that could explain the weak and 
broad NMR signals observed in this region of the molecule. This 
tautomerization could also explain the disappearance of the C-23 methyl 
signal in deuterated, protic NMR solvents (Figure 11).   
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Figure 10: Structural elucidation of erdacin.  
A) Key 1H-1H and 1H-13C NMR couplings used to assemble the two halves of erdacin are 
shown. B) Two key C-15 HMBC correlations from H-13 and H-17 allow the two halves to be 
connected. Extensive NMR analysis was unable to distinguish between two possible 
arrangements of the remaining atoms. C) Ultimately, the structure of erdacin was resolved 
by X-ray crystallography (grey = carbon and red = oxygen). 
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Figure 11: Hydroxy-assisted tautomerization of erdacin.  
Time course charting the rapid loss of the 2.53 ppm C-23 methyl signal from 1HNMR of 
erdacin in MeOD-d4. This is likely the result of a C-2 hydroxy-assisted C-22 carbonyl 
tautomerization. 
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 The X-ray structure confirmed that erdacin is a novel metabolite. 
Neither the erdacin carbon skeleton nor the erdacin pentacyclic (6-6-5-6-6) 
ring system are substructures in known natural products (Figure 12). While 
pentacyclic ring systems with the same number of 5- and 6-membered rings 
are known, the particular arrangement of the erdacin ring system is novel. 
The pentacyclic backbone of erdacin is functionalized with acetyl groups, 
hydroxyls, a ketone and a carboxylate. The structural elucidation of erdacin 
provides evidence that eDNA-derived type II PKS gene clusters can encode 
for metabolites that are structurally distinct from those identified by 
traditional culture-dependent studies. 
 
Figure 12: The novel structure of erdacin.  
Both the carbon skeleton and the pentacyclic ring arrangement of erdacin are novel. 
Juglocombin is a previously reported metabolite with the same number and order of 5- and 6-
membered rings, but the ring system is arranged differently.  
Sequencing of PKS Containing eDNA-derived Clones 
In order to develop a better understanding of the type-II PKS gene 
clusters recovered from the eDNA library, the V167 clone was sequenced 
(Figure 13a). Several contigs resulted from Dr. John Bauer’s 454 sequencing 
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of the V167 clone. Primer walking, conducted for this thesis, to fill the gaps 
between these contigs proved not to be a trivial task due to the very high GC 
content of the eDNA insert. The completed sequencing efforts revealed the 20 
kb erdacin gene cluster containing 22 predicted ORFs. These 22 ORFs 
include the minimal PKS, a ketoreductase, a cyclase, and an aromatase 
expected from a PKS gene cluster. Sequencing of the erdacin minimal PKS 
genes revealed they are most closely related to the minimal PKS genes of the 
naphthocyclinon, actinorhodin, granaticin and medermycin pathways (Figure 
13b). Additionally, a collection of post-PKS enzymes, regulatory proteins, a 
transporter, and several hypothetical proteins are also encoded for by the 
erdacin gene cluster.  
 
Figure 13: The erdacin gene cluster.  
A) The erdacin gene cluster. B) Erdacin minimal PKS genes are most closely related to the 
minimal PKS genes of medermycin, actinorhodin, granaticin and naphthocyclinon gene 
clusters.  
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In addition to sequencing the V167 clone, a number of additional 
clones from the UT and AB libraries were sequenced by Dr. John Bauer and 
myself, respectively. Sequencing of the X26 clone from the UT library 
revealed a truncated PKS gene cluster with a minimal PKS (Figure 14). A 
cosmid that captured an incomplete PKS gene cluster from eDNA could 
explain the array of unstable clone specific metabolites observed in cultures 
of S. albus harboring the X26 clone.  
 
Figure 14: Sequencing of the X26 clone. 
The X26 clone contains a minimal PKS and a truncated PKS gene cluster. Heterologous 
expression of the truncated X26 clone lead to the production of a number of uncharacterized 
unstable metabolites.  
Erdacin Activity 
 With the structure of erdacin elucidated, several assays were 
conducted to explore the potential activity of erdacin. Erdacin (50-100µg/disk) 
was assayed against a number of Gram-positive and Gram-negative microbes 
in an antibacterial agar disk diffusion assay. However, no zone of inhibition 
was observed against the tested microbes. Assays of erdacin against 
mammalian cell lines also showed no activity. Erdacin did, however, show 
strong antioxidant activity. In fact, erdacin demonstrated twice the 
antioxidant activity as the known antioxidant ascorbic acid (vitamin C) as 
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determined by a standard antioxidant copper reduction assay (Apak, Kubilay, 
et al 2004). Since the bacteria that encodes for erdacin remains uncultured, it 
is difficult to know the function of erdacin in its native microbe.  
Isolation of Juglomycin F 
 A number of clone specific novel and known metabolites, in addition to 
erdacin, were characterized from cultures of S. albus conjugated with the 
eDNA-derived V167 clone to develop a better understanding of this type-II 
PKS. In addition to the major metabolite erdacin, a second clone specific 
metabolite was identified in four-day-old SMM cultures of the V167 clone. S. 
albus cultures were extracted and this metabolite was isolated by reversed 
phase HPLC. NMR and MS analysis established the structure of this 
molecule was the known compound juglomycin F, confirming earlier 
observations by Dr. John Bauer of V167 in alternative culture conditions. The 
structure of juglomycin F maps onto half of the erdacin structure, providing a 
hint to the biosynthetic origin of erdacin. This observation raised the 
possibility that erdacin is derived from the heterodimerization of juglomycin 
F and a second 13-carbon subunit (Figure 15).  
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Figure 15: Retrobiosynthetic scheme for the production of erdacin.  
Erdacin appears to arise from two 13-carbon monomers. Juglomycin F, isolated from V167 
cultures, maps onto half of the erdacin structure. The hypothetical second 13-carbon 
polyketide contains the carbons needed to complete the structure of erdacin.  
Isolation and Characterization of Utahmycins and 
Prechrysophanol 
A number of additional compounds were observed in alternative 
culture conditions of S. albus conjugated with the V167 clone.  In these 
alternative conditions, V167 cultures were incubated for a longer time (7-14 
days) in R2YE media instead of SMM media. One of the metabolites produced 
was extracted, isolated using HPLC and identified by NMR, MS and 
crystallography as the known octaketide product prechrysophanol by Dr. 
John Bauer. The isolation of prechrysophanol provides another hint to the 
biosynthetic origin of erdacin suggesting that the erdacin minimal PKS may 
produce a nascent octaketide backbone. 
Three of the remaining compounds observed in R2YE cultures had odd 
masses ([M +H]+ m/z 228, 254, and 268) suggesting they contained a 
nitrogen and were distinct from erdacin and its predicted biosynthetic 
intermediates. Two of these metabolites were extracted and fractionated by 
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silica flash chromatography with a CHCl3/MeOH step gradient. The fraction 
containing both of these compounds was further partitioned by reverse phase 
HPLC. HRMS data was collected on these two metabolites named utahmycin 
A (observed m/z 254.0829 [M + H]+ (calcd for C15H12NO3, 254.0817)) and 
utahmycin B (obsered m/z 228.0672 [M + H]+ (calcd for C13H10NO3, 
228.0661)). The structure of utahmycin B was resolved by Dr. John Bauer 
using MS, 1HNMR and HMBC NMR data. Missing publication quality 
13CNMR, COSY, HMBC, HMQC and other empirical data of utahmycin B 
was collected for this thesis after obtaining more material.  
Work toward this thesis resolved the structure of utahmycin A using 
1H, 13C, COSY, HMBC and HMQC NMR spectra (Figure 16). Proton NMR of 
utahmycin A revealed two methyl singlets, four aromatic protons and an 
alcohol. COSY and 1HNMR showed three of the aromatic protons form a 
proton spin system (d-t-d) and the remaining aromatic proton is a singlet. 
Carbon NMR and HMQC revealed the two methyl carbons, two carbonyls, 
three olefins directly attached to heteroatoms, four olefins attached to a 
hydrogen and four additional olefins. The H-5, 6 and 7 proton spin system 
could be assembled into an aromatic ring with C-8, 11 and 12 based on 
HMBC correlations. The high deshielding of C-8 and HMBC correlations from 
the alcohol to C-7, 8 and 12 enabled the alcohol to be positioned on C-8. One 
of the two carbonyls (C-10) could be placed adjacent to C-11 based on an 
HMBC correlation between H-5 and C-10. C-10 also had an HMBC 
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correlation to the singlet H-4. Additional HMBC correlations from H-4 to C-3, 
13, 14 and 16 were used to assemble the framework for the second half of 
utahmycin A. This was further supported by correlations from the methyl H-
16 protons to C-3 and C-4. The second methyl group and the final olefin could 
both be connected to the structure based on correlations between H-15 
protons and C-1 and 13. In this structure both of the methyl groups are 
attached to deshielded olefins (C-1 and C-3) that are attached directly to a 
heteroatom. With only a nitrogen and carbonyl left to place, the only way to 
satisfy the deshielded 13C chemical shifts is to connect C-1 and C-2 through a 
nitrogen. The remaining carbonyl (C-9) could then only be placed one way to 
meet the unsaturation requirements of the chemical formula, between C-12 
and C-13. The structure of utahmycin A was further confirmed by X-ray 
crystallography.   
 
Figure 16: Structural elucidation of Utahmycin A and B.  
A) Key 1H-1H and 1H-13C correlations used to elucidate the structures of Utahmycin A (24) 
and B (25) are shown. B) The structure of Utahmycin A was confirmed by X-ray 
crystallography (grey = carbon, red = oxygen and blue = nitrogen). 
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 The third nitrogen-containing metabolite, obtained in much lower 
titers (< 0.5mg/L), was isolated. HRMS and 1HNMR of this metabolite, 
suggested a compound related to the other two utahmycins. The absence of a 
hydroxyl signal and the appearance of a deshielded methyl group in 1HNMR 
was consistent with HRMS data (HRMS (ESI) m/z 268.0953 [M+H]+, calcd. 
for C16H14NO3, 268.0974) and an O-methylation of utahmycin A.  
The structure of Utahmycin A is novel and is the first 1,3-dimethyl-2-
azaanthrqquinone reported from a biological system. While utahmycin B has 
been previously synthesized, it has not been observed in a biological system. 
2-azaanthraquinones have primarily been isolated from fungi and lichens 
and present a wide range of activity from antibacterial to antimalarial 
activity (Figure 17b) (Zhang, Watanabe et al. 2006). In fungi 2-
azaanthraquinones are typically found with structurally related metabolites, 
which contain an oxygen in place of the nitrogen of 2-azaanthraquinones 
(Medentsev, Akimenko et al. 1988; Parisot, Devys et al. 1990; Kurobane, 
Vining et al. 1980; Kurobane, Zaita et al. 1986). No antibiotic activity was 
observed when utahmycin A and B (50-100µg/disk) were assayed against a 
number of Gram-positive and Gram-negative microbes in a disk diffusion 
assay. The isolation of erdacin, utahmycin A, utahmycin B and  8-O-
methylutahmycin A from a single eDNA-derived clone, indicates that eDNA-
derived type-II PKS gene clusters are a rich source of novel natural products. 
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Figure 17: Metabolites of the eDNA-derived V167 clone.  
A) Multiple metabolites were isolated from S. albus transformed with the V167 clone. These 
included the novel structure erdacin, utahmycin A, utahmycin B, 8-O-methylutahmycin A 
and the known polyketide prechrysophanol. B) Known 2-azaanthraquinones. 
Biosynthesis of Erdacin 
Knockouts and octaketide shunt products 
A biosynthetic analysis of the eDNA-derived type-II PKS gene cluster 
that encodes for the novel structure and pentacyclic ring arrangement of 
erdacin was done. This biosynthetic analysis included transposon 
mutagenesis experiments to generate a number of single gene knockout 
erdacin gene clusters. Single gene knockouts of the retrofitted V167 clone 
were created by insertion of a chloramphenicol resistance gene using the 
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Genome Priming System with GPS®-2.1 (NEB, Ipswich, MA). The location of 
insertion was determined for 150 unique transposon mutants by Sanger 
sequencing. Due to the high GC content (>90%) of large regions of the Erd 
gene cluster, transposon insertions did not distribute evenly throughout the 
eDNA insert and, therefore, no transposon insertions were identified in 
several GC rich genes. A large number of unique transposon mutants were 
individually mated into S. albus and visually screened for phenotypic 
changes. The chemotypes of individual transposon mutants, which either 
exhibited a phenotypic change or were found in genes of interest by 
sequencing, were analyzed by analytical LC-MS and TLC of culture extracts.  
Transposon mutants effecting the expression of erdacin all fell within a 
20 kb region of the V167 clone, which was defined as the erdacin gene cluster 
(Figure 18b). The 20 kb erdacin gene cluster contains 22 predicted ORFs 
including the expected minimal PKS (Erd1, -2, and -3), ketoreductase (Erd5), 
cyclase (Erd22) and aromatase (Erd4) of PKS gene clusters. A collection of 
post-PKS enzymes, regulatory proteins, a transporter, a 4'-
phosphopantetheinyl transferase and several hypothetical proteins are also 
located within the gene cluster. Transposon knockouts of the minimal PKS 
(Erd-1, -2, and -3) and a transcriptional activator (Erd-9) abolished clone 
specific secondary metabolite production. And clones with insertions in Erd4, 
-5, -20 and -22 showed a change in chemotype by visual inspection and LC-
MS of extracts (Figure 18a) 
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Figure 18: V167 transposon mutants. 
A) Color changes observed in extracts of S. albus conjugated with mutant erdacin gene 
clusters. B) The locations of key transposon insertions in the erdacin gene cluster. 
 
The compounds found in extracts of S. albus transposon mutants 
ΔErd4, -5, -20 and -22 were extracted, isolated and identified by MS and 
NMR to develop a better understanding of the erdacin gene cluster. Extracts 
of ΔErd5 ketoreductase mutant cultures were found to contain the known 
octaketide shunt products SEK4b and AUR367. These two compounds are 
derived from an alternative first cyclization that occurs when the nascent 
polyketide backbone partially falls off the minimal PKS (Fu, Hopwood et al. 
1994; Seow, Meurer et al. 1997). This alternative first cyclization indicates a 
failure of the minimal PKS to cyclize the nascent polyketide backbone and is 
known to occur when the proper minimal PKS-ketoreductase complex does 
not form (other Ref on ketoreductase). Two more known octaketide shunt 
products, mutactin and dehydromutactin, were isolated from extracts of the 
ΔErd4 aromatase mutant. The presence of mutactin and dehydromutactin is 
consistent with an octaketide PKS gene cluster with an aromatase knockout 
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(Zhang, Adefarati et al. 1990; Fu, Khosla et al. 1994; Staunton and 
Weissman 2001; Meisner, Hintersteiner et al. 2007). Furthermore, SEK34 
and SEK34b were isolated from crude extracts of the ΔErd22 cyclase mutant. 
X-ray crystallography was used to confirm the structure of SEK34b. The 
observation of SEK34 and SEK34b is consistent with a cyclase knockout 
(McDaniel, Khosla et al. 1994; Staunton and Weissman 2001). The deletion 
of Erd20, a predicted FAD-dependant monooxygenase, led to the production 
of the known octaketide product prechrysophanol (also identified in R2YE 
cultures of wild-type V167) and a number of other compounds with a range of 
molecular weights from m/z 240 to 315.  
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Figure 19: Biosynthetic scheme of metabolites produced by V167 early post-PKS 
gene knockouts.  
SEK4b, AUR367, mutactin, dehydromutactin, SEK34 and SEK34b were isolated from 
cultures of early erdacin PKS gene knockouts. These metabolites isolated from cultures of 
ΔErd4, ΔErd5 or ΔErd22 mutants are known octaketide metabolites, indicating erdacin is 
derived from a 16-carbon backbone. 
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Figure 20: Biosynthetic scheme for the production of erdacin.  
Evidence indicates that erdacin may be derived from the dimerization of two 13-carbon 
subunits, but the erdacin minimal PKS appears to produce an octaketide. A biosynthetic 
scheme for the production of these two 13-carbon monomers from an octaketide is shown. 
Utahmycin A, utahmycin B and prechrysophanol, isolated from wild type V167 cultures, are 
derived from intermediates in the proposed biosynthesis of erdacin.  
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Knockouts of early PKS genes lead to the production of known 
octaketide shunt products, suggesting that the minimal PKS of erdacin 
produces an octaketide backbone. However, the isolation of juglomycin F from 
wild type cultures hints that erdacin is derived from the heterodimerization 
of two distinct 13-carbon subunits (Figure 15). A biosynthetic scheme is 
proposed where two 13-carbon subunits of erdacin are derived from the 
excision of three carbons from octaketide precursors produced by the minimal 
PKS (Figure 19 and 20). While the isolation of juglomycin F from wild type 
cultures supports the existence of one 13-carbon intermediate, the second 13-
carbon subunit was not identified. The two most likely possibilities of the 
origin of the second 13-carbon subunit share a common first cyclization with 
the juglomycin F monomer and are then derived from a rearrangement or an 
alternate second cyclization (Figure 20). This biosynthetic scheme is further 
supported by the isolation of prechrysophanol (27), utahmycin A (24) and 
utahmycin B (25), which are derived from various biosynthetic intermediates 
of erdacin production. Prechrysophanol, observed in wild type and ΔErd20 
mutant cultures, is a known decarboxylated octaketide and its biosynthesis is 
understood. Utahmycin A and B both appear to be derived from the 
incorporation of nitrogen into erdacin biosynthetic intermediates (Figure 20).  
Further evidence that the erdacin minimal PKS produces an 
octaketide comes from sequencing data that revealed Erd1, -2, and -3 are 
most closely related to the minimal PKS genes of the octaketide encoding 
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naphthocyclinon, actinorhodin, granaticin and medermycin pathways (Figure 
13). Naphthocyclinon (22) and actinorhodin (13) are both octaketide dimers, 
which arise from two different dimerization strategies (McDaniel, Khosla et 
al. 1994; Ichinose, Bedford et al. 1998; Brucker, McKinney et al. 1999; 
Ichinose, Ozawa et al. 20003). Interestingly, erdacin appears to use an 
alternative octaketide heterodimerization strategy.  
Cyclization Pattern of Erdacin 
Knockout experiments suggest that octaketide precursors are 
converted into two 13-carbon monomer subunits that heterodimerized to 
produce erdacin. One of these 13-carbon monomers is represented by 
juglomycin F, isolated from wild type V167 cultures. A number of possibilities 
of the origin of the unidentified second 13-carbon subunit exist, including the 
two most likely possibilities that share a common first cyclization with the 
juglomycin F monomer and are then derived from a rearrangement or an 
alternate cyclization. An [1,2-13C]acetate feeding experiment was conducted 
to distinguish the numerous folding pattern possibilities that could result in 
the second 13-carbon monomer.  
Cultures of the V167 clone were feed one part labeled [1,2-13C]acetate 
and two parts naturally abundant acetate. The labeled [1,2-13C]acetate units 
were incorporated into erdacin by the bacteria during biosynthesis and the 
resulting labeled erdacin was isolated. On average, every incorporated 
labeled acetate unit was adjacent to two non-labeled acetate units. 13C-13C 
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coupling between the two carbons of labeled acetate units in 1- and 2D 
13CNMR of [1,2-13C]acetate-labeled erdacin was then used to determine which 
carbons in erdacin were incorporated as intact acetate units. For example, C-
23 appears as a singlet in 13CNMR of [1,2-13C]acetate-labeled erdacin, 
however, C-23 shows coupling to C-22 and appears as a doublet in 13CNMR of 
erdacin that is uniformly labeled with 13C (Figure 21a). The absence of 
coupling between C-23 and C-22 in the acetate labeled erdacin indicates that 
C-22 and C-23 arise from different acetate units during biosynthesis.  
The experimentally observed folding pattern of erdacin is consistent 
with the octaketide (Sʹ′)-folding of the juglomycin F monomer in the proposed 
biosynthetic scheme (Figure 20). Specifically, observed coupling between C-20 
to C-21, C-18 to C-19, and C-16 to C-17 of erdacin in these labeling 
experiments supports the proposed folding pattern of the juglomycin F 
monomer of erdacin (Figure 21, 22a). This proposed folding pattern is further 
supported by the absence of coupling between C-23 and C-22 in 1D 13CNMR 
acetate labeled experiments, which can be observed by 13CNMR if erdacin is 
uniformly 13C-labeled (Figure 21a). This folding pattern of the juglomycin F 
monomer resembles the octaketide Streptomyces (Sʹ′)-folding of chrysophanol 
and actinorhodin (Bringmann, Irmer et al. 2009). Utahmycin A and B are 
also derived from this octaketide folding pattern. This differs from other 
known 2-azaanthraquinones, which are derived from a fungal (F)-folding of a 
septaketide (Thomas 2001; Van Wagoner, Mantle et al. 2008). Utahmycin A 
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and B are derived from both an alternative folding pattern and a larger 
polyketide precursor than previously known fungal 2-azaanthraquinones. 
There are a number of possibilities for the biosynthetic origins of the 
hypothetical second 13-carbon subunit (Figure 22b). The two most likely 
possibilities share a common first cyclization with the juglomycin F monomer 
and are then derived from a rearrangement (i) or an alternate cyclization (ii). 
If the two 13-carbon monomers share common first and second cyclization 
patterns and the second monomer arises from a rearrangement (i), coupling 
between C-26 and C-25 is expected, but C-24 would not couple with the 
adjacent C-12 in erdacin. However, these couplings expected of this folding 
pattern were not observed in 2D INADEQUATE experiments (Figure 21a). In 
fact, coupling was observed between C-24 and C-12, but coupling was not 
observed for C-26. Furthermore, C-25 and C-13 appear to come from the same 
acetate unit, as coupling was observed between them. This 2D 
INADEQUATE data was supported by 1D 13CNMR data comparing 13C-13C 
coupling of uniformly 13C-labled and [1,2-13C]acetate-labeled erdacin (Figure 
21a). This observed coupling is consistent with the second monomer arising 
from a common first cyclization, but an alternative second cyclization to the 
juglomycin F monomer (ii). This folding pattern of an alternative second 
cyclization (ii) is the most likely biosynthetic possibility supported by the 
observed data.  
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Figure 21: The cyclization pattern of erdacin and two 13-carbon precursors.  
(A) Observed 13C-13C coupling of [1,2-13C]acetate-labeled erdacin in 13CNMR and 
INADEQUATE NMR spectra. (B) Coupling data suggests the two 13-carbon monomers that 
make up erdacin are derived from two different cyclization patterns.  
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Figure 22: Biosynthetic possibilities of the labeled acetate feeding experiment.  
The expected carbon couplings of several possible folding patterns for the 13-carbon 
monomers that makeup erdacin and the experimentally determined folding patterns of the 
two monomers. (A) The observed folding pattern of erdacin is consistent with the proposed 
octaketide (Sʹ′)-folding of the Juglomycin F monomer similar to chrysophanol and 
actinorhodin (Figure 20). (B) Several possibilities for the biosynthetic origins of the second 
13-carbon monomer are shown. (i) The second 13-carbon monomer could share a common 
first and second cyclization with the juglomycin F monomer and arise from a rearrangement 
of one of the carbons. The expected folding pattern of this possibility is not consistent with 
the observed folding pattern of the second ring. (ii) The second monomer could be derived 
from a common first cyclization, but an alternative second cyclization (Figure 20). The 
observed folding pattern is consistent with the expected folding pattern of this possibility and 
is the most likely biosynthetic possibility supported by the observed data. (iii) Another 
alternative second cyclization is also consistent with the observed data, but can be ruled out 
as it is inconsistent with known polyketide biosynthesis. (iv) An alternative first cyclization 
that resembles the fungi specific (F)-folding pattern is an unlikely possibility, as the erdacin 
gene cluster appears to be derived from Streptomyces. (v) The expected folding pattern of 
another alternative first cyclization resulting in (S)-folding similar to chrysophanol is not 
consistent with the observed folding pattern of the second ring. (vi) Another possibility could 
have the same first (S)-folding cyclization as v, but have an alternative second cyclization 
pattern. The expected folding pattern of this possibility is also consistent with the observed 
folding pattern, however, this possibility is unlikely as it would require the minimal PKS of 
erdacin to catalyze two different first cyclization reactions.  
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Another biosynthetic possibility for the origin of the second 13-carbon 
monomer of erdacin is a second folding pattern that shares a common first 
cyclization with the juglomycin F monomer, but has an alternative second 
cyclization (iii). In this biosynthetic possibility, the second 13-carbon 
monomer would arise from a rearrangement and loss of three carbons from 
the (S`)-folded octaketide 34. Alternatively, the same coupling pattern could 
be derived from the loss of three carbons from the (S)-folded octaketide 35. In 
either case, the expected coupling of this folding pattern would be consistent 
with the observed data (Figure 22b iii), but inconsistent with polyketide 
biosynthesis. In fact, this possibility would require the addition of an oxygen 
functional group to four different carbon positions and the removal of oxygen 
from at least two additional carbons. Possibility iii is consistent with 
observed data, but can be ruled out because it is inconsistent with known 
polyketide biosynthesis.  
Three other possibilities arise from alternative first cyclizations of the 
octaketide backbone. An alternative first cyclization that resembles the fungi 
specific (F)-folding pattern is inconsistent with observed data and is unlikely 
as the erdacin gene cluster appears to be derived from Streptomyces (iv). The 
expected folding pattern of an alternative first cyclization leading to (S)-
folding is inconsistent with the observed folding pattern of the second ring 
(v). However, another possibility could share a first (S)-folding cyclization 
with possibility v, but have an alternative second cyclization pattern (vi). The 
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expected folding pattern of this possibility is also consistent with the 
observed folding pattern. However, this possibility is unlikely as it would 
require the minimal PKS of erdacin to catalyze two different first cyclization 
reactions. Furthermore, a rearrangement would be required, making 
possibility vi far more complex than ii.  
The possibility most consistent with known biosynthetic precedent that 
was supported by 1- and 2D 13CNMR data from the acetate feeding 
experiment, suggests the second 13-carbon monomer shares a first cyclization 
with the juglomycin F monomer and then arises from an alternate second 
cyclization. Interestingly, the biosynthetic scheme suggested by this data 
utilizes an alternate second cyclization, but results in the same three carbons 
being excised from the octaketide precursors of both monomers (Figure 21b). 
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CHAPTER 4 
Discussion  
Abundance of type II PKS gene clusters in eDNA from soil  
Uncultured bacteria are thought to encode for a plethora of previously 
undiscovered small molecules. Libraries of DNA isolated from environmental 
samples were used to access the genetic diversity of these uncultured 
microbes. Previous studies have indicated that eDNA samples are rich in 
Type II PKS genes (Wawrik, Kerkhof et al. 2005; Pang, Tan et al. 2008; 
Wawrik, Kutliev et al. 2007). Sequencing of KSβ gene amplicons from the UT 
and AB libraries confirmed eDNA libraries are rich in PKS gene clusters. In 
fact, 21 unique KSβ genes were amplified from the UT library and another 31 
were identified in the AB library. Only two of the genes identified in the AB 
and UT libraries showed greater than 80% identity to known KSβ genes. The 
remaining pathways all had less than 80% identity to previously sequenced 
KSβ genes and likely encode for novel small molecules. However, no new 
metabolites have been produced from eDNA-derived type II PKS gene 
clusters prior to this work. 
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Novel structures from uncultured bacteria 
To explore the structural diversity encoded by uncultured bacteria, 
cosmids containing type II PKS gene clusters were recovered from an eDNA 
library using KSβ genes as a probe. The recovered clones were heterologously 
expressed in S. albus and screened for the production of clone specific 
metabolites. A number of the clones isolated from the AB and UT libraries 
were found to produce clone specific metabolites. One of these clones (V167) 
was selected for further characterization, because it produced large 
quantities of a stable clone specific metabolite. The molecule the V167 clone 
encodes for was structurally elucidated. This metabolite, erdacin, was found 
to have not only a novel carbon skeleton, but also a novel pentacyclic ring 
arrangement. The structural elucidation of the novel secondary metabolite 
erdacin provides tangible evidence that eDNA-derived type II PKS gene 
clusters have the potential to encode for metabolites that are structurally 
distinct from those identified by culture-dependent studies.  
In addition to erdacin, a number of other clone specific novel and 
known metabolites were characterized from cultures of S. albus harboring 
the V167 clone. These metabolites included utahmycin A, utahmycin B and 8-
O-methylutahmycin A. The structure of Utahmycin A is novel and utahmycin 
B has not been previously observed in a biological system. The utahmycins 
appear to arise from the incorporation of nitrogen into erdacin biosynthetic 
intermediates. Since there is no predicted amino transferase in the erdacin 
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gene cluster, the utahmycins are likely derived from erdacin biosynthetic 
intermediates independent of the erdacin gene cluster. Whether the 
utahmycins have a biological function in the uncultured microbe from which 
the erdacin gene cluster was derived or if they are unintended shunt products 
of erdacin biosynthesis is unknown. Regardless, the isolation of additional 
distinct novel metabolites from the same eDNA clone encoding the 
biosynthesis of erdacin, suggests that eDNA-derived type-II PKS gene 
clusters are a rich source of natural products. 
Sequencing of KSβ amplicons has found the AB and UT eDNA libraries 
are rich in type II PKS gene clusters.  The isolation of the novel metabolite 
erdacin provides tangible evidence that these eDNA-derived gene clusters may 
encode for the biosynthesis of small molecules that are distinct from compounds 
isolated by culture-dependant strategies. Isolation of the utahmycins suggests 
that heterologous expression of these PKS gene clusters may yield, in some 
cases, multiple metabolites from a single clone. There is now precedent that 
the recovery and screening of clones, containing eDNA-derived type II PKS 
gene clusters, for the ability to confer production of clone-specific metabolites 
to Streptomyces will be a rewarding avenue to access the structural diversity 
of natural products encoded by uncultured soil bacteria.  
 
69 
 
Biosynthesis of erdacin and the utahmycins 
The novel structure and pentacyclic ring arrangement of erdacin raised 
questions as to its biosynthetic origins. To develop a better understanding of 
the origin of erdacin, a biosynthetic analysis of the V167 clone utilizing 
transposon mutagenesis and [1,2-13C]acetate feeding experiments was 
conducted. The isolation of juglomycin F from wild type V167 cultures, 
provided an initial hint to the biosynthetic origin of erdacin. The structure of 
juglomycin F maps onto half of the erdacin structure; suggesting it may arise 
from the heterodimerization of two 13-carbon subunits. However, transposon 
knockouts of early PKS genes lead to the production of known octaketide 
shunt products, indicating that the minimal PKS of erdacin produces an 
octaketide backbone. A minimal PKS encoding an octaketide is further 
supported by the isolation of the octaketide product prechrysophanol from 
cultures of mutant and wild type V167. Additionally, the folding pattern 
leading to the novel ring system of erdacin was assessed in an [1,2-
13C]acetate feeding study to learn more about the origins of the two 13-carbon 
subunits that make up erdacin.  
While the exact structure of late-stage polyketides used in erdacin 
biosysnthesis is unknown, a biosynthetic scheme where erdacin is derived 
from two 13-carbon subunits was proposed. In this biosynthetic scheme, the 
erdacin minimal PKS encodes for an octiketide and the two distinct 13-carbon 
monomers are derived from a common octaketide precursor. Two distinct 
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second cyclizations diverge the biosynthesis of the two 13-carbon 
intermediates. At some point, both of the 13-carbon intermediates have the 
same three carbons excised from their octaketide precursors. These two 13-
carbon monomers would then heterodimerize to form erdacin.  
The utahmycins appear to arise from the incorporation of nitrogen into 
erdacin biosynthetic intermediates. There is no predicted amino transferase 
in the erdacin gene cluster and the utahmycins are likely derived from 
biosynthetic intermediates independently of the erdacin gene cluster. Data 
from [1,2-13C]acetate-label erdacin implies the folding pattern of the 
utahmycins resembles the octaketide Streptomyces (Sʹ′)-folding of 
chrysophanol (Bringmann, Irmer et al. 2009). This differs from other known 
2-azaanthraquinones, which are derived from a fungal (F)-folding of a 
septaketide (Thomas 2001; Van Wagoner, Mantle et al. 2008). Utahmycins 
are derived from both an alternative folding pattern and a larger polyketide 
precursor than previously known fungal 2-azaanthraquinones. 
Activity of eDNA-derived metabolites  
Since the bacteria that eDNA is derived from remain uncultured, it can 
be difficult to determine the function of novel eDNA-derived metabolites in 
their native organism. No antibacterial activity was detected when erdacin 
and the utahmycins were assayed against a number of Gram-positive and 
Gram-negative microbes in an antibacterial agar disk diffusion assay. And 
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erdacin did not appear to have an effect when cultured with mammalian cell 
lines. Erdacin was, however, found to have twice the antioxidant activity as 
the known antioxidant ascorbic acid (vitamin C).  
Cryptic eDNA-derived clones and future directions 
In addition to the V167 clone, a number of other clones containing PKS 
genes were recovered from the UT and AB libraries. Screening of the recovered 
clones containing minimal PKS genes revealed a number of clones able to confer the 
production of clone-specific molecules to cultured Streptomyces albus. However, 
some of the clones recovered from the libraries produced a large amount of 
unstable clone specific metabolites and others were cryptic clones. The X26 
clone is one such cosmid that produced an array of unstable metabolites. Dr. 
John Bauer’s sequencing of X26 revealed a minimal PKS and truncated gene 
cluster. A cosmid that captured an incomplete PKS gene cluster from eDNA 
could explain the array of unstable clone specific metabolites observed in X26 
cultures. 
The	  ability	  to	  access	  the	  metabolites	  encoded	  by	  these	  truncated	  and	  cryptic	  pathways	  would	  greatly	  increase	  the	  number	  of	  novel	  compounds	  found	  from	  eDNA	  libraries.	  A	  number	  of	  strategies	  have	  been	  utilized	  in	  subsequent	  studies	  to	  access	  the	   structural	   diversity	   of	   these	   PKS	   gene	   clusters.	   In	   one	   approach,	  missing	   PKS	  biosynthetic	   enzymes	   not	   present	   in	   the	   truncated	   X26	   clone	   were	   found	   by	  recovering	   a	   second	   overlapping	   eDNA	   clone	   representing	   the	   same	   PKS	   gene	  cluster.	  The	   reconstruction	  of	   these	   two	  overlapping	   clones	   into	  a	   single	  Bacterial	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artificial	   chromosome	   (BAC)	   and	   the	   subsequent	   heterologous	   expression	   of	   the	  reconstructed	  PKS	  pathway	  resulted	  in	  the	  discovery	  of	  a	  second	  novel	  ring	  system	  from	  eDNA	  (Kim,	  Feng	  et	  al.	  2010;	  Feng	  ,	  Kallifidas	  et	  al.	  2011;	  Kallifidas	  and	  Brady	  2012).	  
While S. albus has been utilized with great success in this work and 
subsequent studies to heterologously	   express eDNA-derived PKS gene 
clusters, alternative Streptomyces heterologous hosts may more closely 
resemble some of the uncultured native organisms that these eDNA gene 
clusters are derived from. In fact, it has been reported that eDNA clones will 
present distinctive phenotypes in different hosts and that the same 
phenotype is rarely conferred to two different hosts (Craig, Chang et al. 2009; 
Craig, Chang et al. 2010). Expression of eDNA-derived PKS gene clusters in 
alternative Streptomyces heterologous hosts may lead to the production of 
metabolites from cryptic clones (Wang, Isaacs et al. 2009; Komatsu, 
Uchiyama et al. 2010). Another approach to accessing the metabolites 
encoded by cryptic eDNA clones is through the overexpression of 
transcription factors from eDNA-derived PKS gene clusters. A recent study 
has reported the successful use of a constitutively expressed pathway-specific 
Streptomyces antibiotic regulatory protein to promote the production of 
tetarimycin A from a previously cryptic eDNA clone (Kallifidas, Kang et al. 
2012).  
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An alternative strategy to increase the number of natural products 
discovered from eDNA libraries is to build a library enriched with PKS gene 
clusters. Recently, the complementation of phosphopantetheine transferase 
(PPTase) deletion mutants with the PPTase genes found in some eDNA 
clones was successfully leveraged as a filter to construct an NRPS/PKS 
enriched eDNA library (Charlop-Powers, Banik et al. 2013). These advances 
and additional new approaches will continue to enhance our ability to access 
the incredible structural diversity of natural products that are encoded by 
uncultured bacteria.  
Sequencing advances and future directions 
 As sequencing technology continues to develop in both speed and cost 
effectiveness it will have a profound impact on the field of metagenomics 
(Chan, Hsu, et al. 2008; Morozova and Marra 2008; Yang, Peng et al. 2010). 
In fact, there are already efforts to sequence the first complete soil 
metagenome (Vogel, Simonet, et al. 2009). The data presented here and in 
other studies indicates that the genetic diversity encoded by uncultured 
bacteria is an affluent source of natural products that are distinct from those 
identified by traditional culture-dependant studies. Metagenomic methods 
will likely be a rewarding avenue for future research efforts. 
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APPENDIX 
Table 8: Chemical shift table of Erdacin in MeOD with 0.1% TFA. 
Atom # Chemical δ  Proton δ  (J Hz) 1H-13C HMBC 
1 188.4      
2 153.7      
3 127.7      
4 131.2      
5 143.3      
6 133.4      
7 120.6  7.16 (d, 7.1, 1H) 5, 6, 8, 9, 11 
8 131.3  7.28 (t, 7.7, 1H) 6, 7, 10, 11 
9 118.7  6.92 (d, 7.7, 1H) 6, 7, 8, 10, 11, 12 
10 156.7     
11 123.8     
12 75.5      
13 64.6  4.29 (s, 1H) 5, 11, 12, 14, 15, 24, 25, 26 
14 134.6      
15 130.6      
16 135.6      
17 119.1  7.40 (m, 1H) 15, 16, 19, 20, 21 
18 138.8 7.40 (m, 1H)   
19 118.4  6.73 (d, 7.7, 1H) 17, 20, 21 
20 165.3      
21 114.1      
22 205.5      
23 30.3   2.53 (s, 3H) 4, 22 
24 176.6     
25 203.5     
26 27.9  1.72 (s, 3H) 13, 25 
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Table 9: Genes of the Erdacin pathway and their deduced role. 
Gen
e Size  Deduced Role Homologues 
  (aa)   Gene Deduced role 
% 
SM/I
D  Origin accession # 
ORF
4 251  SSAG_02590 Acetyltransferase 77/72 Streptomyces sp. EDX22799 
Erd 
1 430 Keto-acyl synthase α (KSα) ORF1 Keto-acyl synthase α (KSα) 94/90 S. antibioticus CAC05671 
Erd 
2 407 Keto-acyl synthase β (KSβ) ORF2 Keto-acyl synthase β (KSβ) 83/72 S. antibioticus CAC05672 
Erd 
3 89 Acyl carrier protein (ACP) ORF3 Acyl carrier protein (ACP) 87/77 S. antibioticus CAC05673 
Erd 
4 316 Aromatase ORF4 putative aromatase 82/71 S. antibioticus CAC05674 
Erd 
5 261 Keto reductase ORF5 putative keto reductase 92/86 S. antibioticus CAC05675 
Erd 
6 153 ActVI-A like gra-orf31 unknown/aromatase 78/66 S. violaceoruber CAA09658 
Erd 
7 317 Acyl-CoA dehydrogenase YP_002192995 acyl-CoA dehydrogenase 39/28 S. clavuligerus YP_002192995 
Erd 
8 266 
4'-phosphopantetheinyl 
transferase pSLA2-L_p056 4'-phosphopantetheinyl transferase 59/50 S. rochei NP_851478 
Erd 
9 272 
Pathway-specific 
transcriptional activator gra-orf9 AlnR3 SARP family regulator 71/59 S. violaceoruber CAA09630 
Erd 
10 192 HP ABB04148 phenylalanine ammonia lyase 39/31 Rhodotorula glutinis ABB04148 
Erd 
11 395 
Two component sensory 
kinase gra-orf11 two-component sensory kinase 54/40 S. violaceoruber CAA09632 
Erd 
12 191 
Two-component response 
regulator gra-orf10 two-component response regulator 81/65 S. violaceoruber CAA09631 
Erd 
13 413 Major facilitator transporter RHA1_ro10147 major facilitator transporter 64/50 Rhodococcus sp. YP_708498 
Erd 
14 344 Putative aldo/keto reductase AZC_4378 Putative aldo/keto reductase 66/52 
Azorhizobium 
caulinodans YP_001527294 
Erd 
15 226 Membrane protein RPC_3500 HP 69/56 
Rhodopseudomonas 
palustris YP_533359 
Erd 
16 110 HP ZP_01548508 putative glyoxalase family protein 44/28 Labrenzia aggregata ZP_01548508 
Erd 
17 157 HP RTM1035_00205 HP 55/42 Roseovarius sp. ZP_01881455 
Erd 
18 104 Transcriptional regulator RSal33209_1249 
MarR family transcriptional 
regulator 75/58 
Renibacterium 
salmoninarum YP_001624400 
Erd 
19 206 Flavodoxin SGR_4078 putative flavodoxin 79/66 S. griseus YP_001825590 
Erd 
20 406 
FAD-dependent 
monooxygenase remO FAD-dependent monooxygenase 74/62 S. resistomycificus CAE51184 
Erd 
21 125 
HP/keto reductase Assesory 
protein Aln5 HP/keto reductase Assesory protein 64/48 
Streptomyces sp. 
CM020 ACI88872 
Erd 
22 302 Cyclase gra-orf33 cyclase 74/62 S. violaceoruber CAA09660 
ORF
27 177  SCO0222 acetyltransferase 88/80 S. coelicolor NP_624554 
ORF
28 287   
N5,N10-methylenetetra-
hydromethanopterin reductase 87/79 S. tsusimaensis ABA59536 
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Table 10: NMR Specroscopic Data (CD2Cl2) for Utahmycin A 
 
 
 
position δC, mult. δH (J in Hz) HMBC 
1 162.1, qC   
2    
3 165.2, qC   
4 117.8, CH 7.85, s 3, 10, 13, 16 
5 119.5, CH 7.77, dd (7.5, 1.1) 7, 10, 12 
6 136.9, CH 7.69, t ( 7.9) 7, 8, 11  
7 125.8, CH 7.35, dd ( 8.4, 1.1) 5, 8, 12 
8 163.1, qC   
9 190.3, qC   
10 183.1, qC   
11 133.1, qC   
12 117.2, qC   
13 122.8, qC   
14 117.9, qC   
15 26.8, CH3 3.05, s 1, 13 
16 25.2, CH3 2.70, s 3, 4 
OH  12.78, s 7, 8, 12 
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Table 11: NMR Specroscopic Data (acetone-d6) for Utahmycin B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
position δC, mult. δH (J in Hz) HMBC 
NH (1)   11.77, br, s   
2 140.9, qC     
3 108.2, CH 6.49, s 2, 9, 12, 13 
4 119.7, CH 7.62, m 6, 7, 9, 10, 11 
5 136.5, CH 7.62, m 6, 7, 9, 10, 11 
6 124.5, CH 7.18, dd ( 6.6, 2.8)  4, 5, 7, 11 
7 163.0, qC     
8 180.8, qC     
9 180.5, qC     
10 135.5, qC     
11 116.5, qC     
12 131.9, qC     
13 130.0, qC     
14 13.1, CH3 2.44, s 2, 3 
 OH   12.45, s 6, 7, 11  
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Figure 23: 1HNMR of erdacin in MeOD-d4 with 0.1% TFA 
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Figure 24: 13CNMR of 13C uniformly labeled erdacin in MeOD-d4 with 0.1% TFA 
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Figure 25: 1HNMR of SEK34b in DMSO-d6 
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Figure 26: 1HNMR of Juglomycin F in MeOD-d4 
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Figure 27: 1HNMR of prechrysophanol in Acetone-d6 
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Figure 28: 1HNMR of SEK4b in DMSO-d6 
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Figure 29: 1HNMR of AUR367 in DMSO-d6 
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Figure 30: 1HNMR of Mutactin in Acetone-d6 
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Figure 31: 1HNMR of Dehydromutactin in DMSO-d6 
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Figure 32: 1HNMR of SEK34 in DMSO-d6 
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Figure 33: 1HNMR of utahmycin A in CD2Cl2  
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Figure 34: 13CNMR of utahmycin A in CD2Cl2  
 
 
90 
 
 
 
 
 
 
 
 
Figure 35: 1H-13C HMBC of utahmycin A in CD2Cl2 
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Figure 36: 1H-13C HMQC of utahmycin A in CD2Cl2 
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Figure 37: 1HNMR of utahmycin B in acetone-d6 
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Figure 38: 13CNMR of Utahmycin B in acetone-d6 
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Figure 39: 1H-13C HMBC of utahmycin B in acetone-d6 
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Figure 40: 1H-13C HMQC of utahmycin B in acetone-d6 
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